Uppsala Reports Long Reads – Ending the pregnant pause

Drug Safety Matters

Most women are prescribed some form of medication during their pregnancy. Yet we know very little about the safety of those medicines when they’re used during pregnancy or breastfeeding. New collaborative efforts are now underway to plug that knowledge gap.

This episode is part of the Uppsala Reports Long Reads series – the most topical stories from UMC’s pharmacovigilance magazine, brought to you in audio format. Find the text version here.
Tune in to find out:

• Why clinical trials often fail to include pregnant and breastfeeding women
• What the lack of safety information means for women who need medicines during pregnancy and breastfeeding
• How new multi-disciplinary initiatives are planning to boost pharmacovigilance activities related to pregnancy and lactation

Want to know more?

Read how EUROmediCAT plans to evaluate the safety of medicines in pregnancy in relation to the risk of congenital anomalies.

Find out how ConcePTION wants to help women make informed decisions about the medications they need before, during and after pregnancy.

Read about:

• Lareb’s survey of pregnancy-related pharmacovigilance activities
• the history of women’s involvement in clinical trials
• the ethical debate surrounding the inclusion of pregnant women in research

Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.